恩华药业：公司持续聚焦中枢神经系统药物的开发、生产和销售

Core Viewpoint - The company, Enhua Pharmaceutical, is actively participating in national drug procurement activities to achieve favorable outcomes for its products, focusing on the development, production, and sales of central nervous system (CNS) drugs [1] Group 1: Company Overview - Enhua Pharmaceutical is the only publicly listed company in China dedicated to the research and production of CNS drugs [1] - The company is a designated production base for anesthetic and psychiatric drugs in China [1] - Enhua's product line covers a wide range of CNS drugs, including those for schizophrenia, depression, and analgesia [1] Group 2: Product Portfolio - The company has the most comprehensive product line in the CNS drug sector in China, with 60 approved new drug formulations and 98 product specifications [1] - Enhua holds 7 exclusive products and has 15 first-to-market products [1] - The company has the highest market share in 29 of its products nationwide [1]